IMF unveils $ 50bn plan to end epidemic

IMF unveils $ 50bn plan to end epidemic

“Our proposal sets objectives, assesses financing needs and defines practical actions”, Briefly presented to the International Monetary Fund Managing Director Kristalina Georgieva at the World Health Summit held in Rome within the framework of the G20.

The plan aims to immunize at least 60% of the world’s population by the end of 2022 so that a sustainable global economic recovery can occur.

The authors of the report insist that it is now accepted that there will be none “Permanent end” For an economic crisis without the end of the health crisis. Therefore, it is in the interest of all countries to end this crisis with a definite end.

“For some time now, we have been warning about a dangerous divergence in economic conditions”, The institution’s patron saint remarked.

“It will only get worse when rich countries have access to vaccines and the gap between poor countries widens.”, He mourned.

By the end of April, less than 2% of the African population had been vaccinated, while more than 40% of the population in the United States and more than 20% in Europe had received at least one dose of the vaccine against Kovid, recall. Let’s do IMF.

The epidemic, which particularly affects India badly, may derail global reform.

To get the planet back on the path of development, the IMF is making a series of proposals with the primary objective of filling the vaccine gap facing many developing countries.

It’s about helping “To significantly control the epidemic everywhere for the benefit of all”, Ms. Georgieva insists.

See also  Russia's deputy foreign minister: First talks with US in Geneva were complicated but factual

To meet the immunization objectives of the world’s population, the IMF emphasized that it is necessary to provide additional subsidies to the international Kovacs system by donating additional doses and ensuring free cross-border flow of raw material and vaccine supplements.

Covax was established to prevent rich countries from appropriating most of the precious dosages. But at the moment it is proving to be ineffective.

The IMF’s proposal would cost about $ 50 billion, combining subsidies (at least $ 35 billion), domestic government resources and other funding, the IMF detailed.

  • Cpu


Please enter your comment!
Please enter your name here